These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 2438448

  • 1. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA, Parakhoniak NV, Zubova TA.
    Kardiologiia; 1987 Mar; 27(3):77-81. PubMed ID: 2438448
    [No Abstract] [Full Text] [Related]

  • 2. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K, Zebrowski M, Kancelarczyk WL, Rymaszewski Z.
    Pol Tyg Lek; 1988 Aug 22; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical importance of the regional study of blood serum lipids in arteriosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA, Kontorshchikova KN, Parakhoniak NV.
    Patol Fiziol Eksp Ter; 1986 Aug 22; (2):23-5. PubMed ID: 3714313
    [No Abstract] [Full Text] [Related]

  • 4. [Rheodextran, vasodilating infusion and blood flow properties in patients with obliterative atherosclerosis of the lower extremities].
    Bulvas M, Linhart J.
    Vnitr Lek; 1982 Sep 22; 28(9):902-7. PubMed ID: 6183828
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B, Bielawiec M, Lukjan H, Grabowski R, Korfel B.
    Pol Tyg Lek; 1972 Jan 24; 27(4):133-5. PubMed ID: 5010169
    [No Abstract] [Full Text] [Related]

  • 6. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H, Reuter W, Voigt H, Herrmann W.
    Z Gesamte Inn Med; 1989 Feb 01; 44(3):77-9. PubMed ID: 2728555
    [Abstract] [Full Text] [Related]

  • 7. [Lipid metabolism indices of patients with arteriosclerosis obliterans of the lower extremities].
    Satmari VV, Kucher VN, Portugal' AS, Gribenko VV.
    Vrach Delo; 1984 Feb 01; (2):70-1. PubMed ID: 6719877
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H, Kancelarczyk WL, Zebrowski M, Uchman B.
    Pol Tyg Lek; 1988 Jun 13; 43(24):776-8. PubMed ID: 3237518
    [No Abstract] [Full Text] [Related]

  • 9. [Photo-hemo-correction in the complex treatment of patients with obliterating atherosclerosis of the arteries of the lower limbs].
    Leont'eva NV, Belotserkovskiĭ MV, Rostova NS, Zolotnitskaia VP, Leont'ev SA, Dmitrieva IaV, Dmitrieva LA.
    Vestn Khir Im I I Grek; 2000 Jun 13; 159(6):57-60. PubMed ID: 11209234
    [Abstract] [Full Text] [Related]

  • 10. [The lipid composition of the blood plasma in patients with ischemic heart disease and concomitant arteriosclerosis obliterans of the arteries of the lower extremities].
    Iastrebov GN, Volkov VS, Bel'chenko DI.
    Ter Arkh; 1992 Jun 13; 64(9):61-4. PubMed ID: 1481157
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of low and high molecular weight dextrans on selected serum lipid parameters. 2].
    Rühlmann C, Koksch M, Hohdorf K, Kuklinski B.
    Z Gesamte Inn Med; 1992 Aug 13; 47(8):337-40. PubMed ID: 1384248
    [Abstract] [Full Text] [Related]

  • 12. [Lipoproteins in arteriosclerosis obliterans of the lower limbs].
    Sznajderman M, Rymaszewski Z, Kancelarczyk WL, Kuczyńska K.
    Pol Arch Med Wewn; 1983 Sep 13; 70(3):125-30. PubMed ID: 6657491
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of complex treatment on indicators of lipid metabolism in patients with arteriosclerosis obliterans].
    Polous IuM, Loĭko IK, Kurko VS, Gribenko GP, Golomazov MF.
    Vrach Delo; 1986 Jun 13; (6):4-7. PubMed ID: 3750955
    [No Abstract] [Full Text] [Related]

  • 14. [Blood lipid composition in patients with obliterating atherosclerosis in lower extremities (author's transl)].
    Zapletalová J, Vinogradov S, Puchmayer V, Mares P, Skorepa J.
    Cas Lek Cesk; 1979 Feb 02; 118(5):146-8. PubMed ID: 436141
    [No Abstract] [Full Text] [Related]

  • 15. The lipid pattern in normals and atherosclerotics.
    Leren P, Haabrekke O.
    Acta Med Scand; 1971 Jun 02; 189(6):495-500. PubMed ID: 5113865
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
    Dudaev VA, Gorin VV, Shingireĭ MV, Kliuchnikova ZhI, Diukov IV.
    Kardiologiia; 1984 Jun 02; 24(6):76-9. PubMed ID: 6748497
    [Abstract] [Full Text] [Related]

  • 17. [Phenotyping of the hyperlipoproteinemia in arteriosclerosis obliterans of the lower extremities].
    Il'chuk OS, Pokrasen NM.
    Klin Khir (1962); 1980 Jul 02; (7):51-3. PubMed ID: 7401511
    [No Abstract] [Full Text] [Related]

  • 18. [The dynamics of the lipid metabolic shifts during the naphthalan therapy of patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Gulieva SA.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1992 Jul 02; (3):61-3. PubMed ID: 1413616
    [No Abstract] [Full Text] [Related]

  • 19. [HDL lipids in men with obliterating atherosclerosis of the lower extremities (author's transl)].
    Zák A, Zapletalová J, Puchmayer V, Tvrzická E, Skorepa J.
    Cas Lek Cesk; 1981 Feb 19; 120(7):189-93. PubMed ID: 7226186
    [No Abstract] [Full Text] [Related]

  • 20. [Lipid metabolism in patients with atherosclerotic arterial occlusions of the lower limbs].
    Bel'chenko DI, Kazakov IuI, Iastrebov GN.
    Kardiologiia; 1985 Aug 19; 25(8):84-5. PubMed ID: 4068471
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.